← Return to the Medical Library
Hair health · medical guide

Hair-loss treatments for women

Guide to female pattern alopecia, telogen effluvium, minoxidil, hormonal assessment and individualised options.

female alopeciaminoxidilwomen’s health
Summary and conclusions

The essentials in less than a minute

  • Female hair loss is not a single diagnosis: pattern alopecia, effluvium, alopecia areata and inflammatory processes require different approaches.
  • Topical minoxidil may be useful in female pattern alopecia depending on presentation and evaluation.
  • Finasteride 1 mg is not indicated for women and did not demonstrate efficacy in postmenopausal women in the technical information sheet consulted; In addition, there is serious risk during pregnancy.
  • Irregular periods, acne, excess hair, anemia, or thyroid symptoms can change the evaluation.

Recognize the pattern

Female pattern alopecia usually widens the part and reduces density at the top, often maintaining the frontal line. Telogen effluvium causes more diffuse shedding after childbirth, illness, surgery, weight loss, or stress. The plaques and scar require further evaluation.

Common options

Treatment depends on the cause
OptionWhen is it considered
Topical minoxidilFrequent choice for female pattern; Concentration and schedule depend on the product.
Correct triggersConfirmed deficits, illness, extreme diet or associated medication.
Antiandrogen treatmentsOnly in selected cases, with prescription, contraception when appropriate and specific control.
Camouflage or transplantCosmetic or surgical options after defining stability and diagnosis.

Pregnancy and hormones

Finasteride is contraindicated during pregnancy and pregnant women should not handle crushed or broken tablets. Finasteride 1 mg is not an approved treatment for female hair loss. Other antiandrogens should not be started without specialized evaluation.

Irregular periods, infertility, severe acne or hirsutism may warrant endocrine evaluation, but not all women need hormonal testing.

Minoxidil and pregnancy

The decision during pregnancy or breastfeeding should follow the product information and clinical advice; security should not be assumed because it is applied topically.

Realistic tracking

The response is valued in months with standardized photos. Irritation, facial hypertrichosis, or a routine that is difficult to maintain may require adjusting the option. A rapid loss, inflammation, pain or loss of eyebrows requires dermatology and should not be treated as pattern alopecia without further ado.

P.

Medically reviewed by Dr Paulo

Medical information reviewed for clinical coherence, safety and source quality.

Ordem dos Médicos Portugal 69376

Official and clinical sources

  1. British Association of Dermatologists · Female pattern alopecia
  2. AEMPS · Topical minoxidil: Summary of Product Characteristics (SmPC)
  3. AEMPS · Finasteride 1 mg: Summary of Product Characteristics (SmPC)

Regulatory information may change. Always check the Summary of Product Characteristics (SmPC) and the leaflet of the dispensed presentation.

Do you need a medical evaluation?

We review pattern, evolution, history and treatments to decide if online management is appropriate or if you need in-person dermatology.

See medical consultation